Skip to content
by Legal Desire
24 September 2026

Baker McKenzie Advises Bayer on the Sale of Cancer Treatment Stivarga® to Grünenthal

Advising firms

Deal team

20 lawyers named
LawyerFirmSeniorityPracticeOffice
Daniel Dehghanian Lead Baker McKenzie Partner Corporate/M&A Düsseldorf
Jan Kresken Baker McKenzie Partner Antitrust & Competition Düsseldorf
Dr. Jan Gutsche Baker McKenzie Senior associate Corporate/M&A Düsseldorf
Dr. Martin Altschwager Baker McKenzie Partner Pharma Frankfurt
Anna Fischer Baker McKenzie Associate Pharma Frankfurt
Dr. Nicolas Kredel Baker McKenzie Partner Antitrust & Competition Düsseldorf
Dr. Florian Kotman Baker McKenzie Partner Antitrust & Competition Düsseldorf
Creighton Macy Baker McKenzie Partner Antitrust & Competition Washington, D.C.
Marisa Dieken Baker McKenzie Senior associate Antitrust & Competition Washington, D.C.
Evan Harris Baker McKenzie Senior associate Antitrust & Competition Washington, D.C.
Kirk Crawford Baker McKenzie Other Antitrust & Competition Washington, D.C.
Oksana Simonova Baker McKenzie Partner Antitrust & Competition Kyiv
Volodymyr Nazarchuk Baker McKenzie Associate Antitrust & Competition Kyiv
Seonho Kim Baker McKenzie Partner Antitrust & Competition Seoul
Patrick Wilkening Baker McKenzie Partner IP/IT Düsseldorf
Yannick Filoda Baker McKenzie Associate IP/IT Düsseldorf
Anela Winzig Baker McKenzie Associate IP/IT Frankfurt
Anahita Thoms Baker McKenzie Partner International Commercial & Trade Berlin
Frederik Alexander Dörr Baker McKenzie Associate International Commercial & Trade Berlin
Chiara Marinozzi Baker McKenzie Partner International Commercial & Trade Milan

Stated terms

Stated value
EUR 375m (EUR 375 million)
What the figure measures
Total transaction value
Client
Bayer AGSell-side
Counterparties
Grünenthal (Buy-side)